Transcriptional up-regulation in expression of 5-hydroxytryptamine 2A and transcriptional down-regulation of angiotensin II type 1 receptors during organ culture of rat mesenteric artery

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 6, 2004, Pages 280-287

  Luo, Guogang ^a,b   Xu, Cang Bao ^a,b   Cao, Yong Xiao ^a,b   Edvinsson, Lars ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DACTINOMYCIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; MESENTERIC ARTERY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CYCLOHEXIMIDE; DACTINOMYCIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; INDOLES; MESENTERIC ARTERIES; ORGAN CULTURE TECHNIQUES; POLYMERASE CHAIN REACTION; POTASSIUM; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, SEROTONIN, 5-HT2A; RNA, MESSENGER; SEROTONIN; TRANSCRIPTION, GENETIC; VASOCONSTRICTION;

ANIMALIA;

EID: 10644288499     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.t01-1-pto950506.x     Document Type: Article

References (53)

1. alpha up-regulates 5-HT(2A)-mediated contraction. Brit. J. Pharmacol. 2002, 137, 971-982.
2. Adner, M., L. Cantera, F. Ehlert, L. Nilsson & L. Edvinsson: Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Brit. J. Pharmacol. 1996, 119, 1159-1166.
3. Alafaci, C., I. Jansen, M. A. Arbab, Y. Shiokawa, N. A. Svendgaard & L. Edvinsson: Enhanced vasoconstrictor effector of endothelin in cerebral arteries from rats with subarachnoid haemorrhage. Acta physiol. scand. 1990, 138, 317-319.
4. Bucher, M., J. Hobbhahn & A. Kurtz: Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit. Care. Med. 2001, 29, 1750-1755.
5. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation 1993, 87, 874-880.
6. Chuang, S. S., J. K. Lee & P. A. Mathew: Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Immunology 2003, 109, 432-439.
7. Chamley-Campbell, J. H., G. R. Campbell & R. Ross: Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell. Biol. 1981, 89, 379-383.
8. De Gasparo, M., H. Rogg, M. Brink, L. Wang, S. Whitebread, G. Bullock & P. Erne: Angiotensin II receptor subtypes and cardiac function. Eur. Heart. J. 1994, 15, Suppl. d98-103.
9. Doan, T., P. Farmer, T. Cooney & M. S. Ali: Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. Cell. Signal. 2004, 16, 301-311.
10. 2) release accompanying angiotensin conversion in rat mesenteric vasculature. Eur. J. Pharmacol. 1981, 70, 129-137.
11. Fang, Z. Y. & T. H. Marwick: Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Amer. Heart. J. 2002, 143, 383-390.
12. 2A receptor signal transduction. J. Pharmacol. Exp. Therap. 1998, 284, 346-355.
13. Gschwend, S., R. H. Henning, Y. M. Pinto, D. de Zeeuw, W. H. van Gilst & H. Buikema: Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Brit. J. Pharmacol. 2003, 139, 1317-1325.
14. Hamel, E., C. Assumel-Lurdin, L. Edvinsson, D. Page & E. T. MacKenzie: Neuronal versus endothelial origin of vasoactive acetylcholine in pial vessels. Brain Res. 1987, 420, 391-396.
15. Hansen-Schwartz, J., D. Szok & L. Edvinsson: Expression of ET(A) and ET(B) receptor mRNA in human cerebral arteries. Brit. J. Neurosurg. 2002,16, 149-153.
16. Hansen-Schwartz, J., N. L. Hoel, M. Zhou, C. B. Xu, N. A. Svendgaard & L. Edvinsson: Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003, 52, 1188-1195.
17. Haywood, G. A., L. Gullestad, T. Katsuya, H. G. Hutchinson, R. E. Pratt, M. Horiuchi & M. B. Fowler: AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997, 95, 1201-1206.
18. Henriksson M., C. B. Xu & L. Edvinsson: Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Brit. J. Pharmacol. 2004, 142, 1155-1161.
19. Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena & P. P. Humphrey: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 1994, 46, 157-203.
20. Lassegue, B., R. W. Alexander, G. Nickenig, M. Clark, T. J. Murphy & K. K. Griendling: Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol. Pharmacol. 1995, 48, 601-609.
21. Lincoln, J., A. Loesch & G. Burnstock: Localization of vasopressin, serotonin and angiotensin II in endothelial cells of the renal and mesenteric arteries of the rat. Cell. Tissue. Res. 1990, 259, 341-344.
22. Makita, N., N. Iwai, T. Inagami & K. F. Badr: Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 1992, 185, 142-146.
23. Miranda, F. J., J. A. Alabadi, G. Torregrosa, J. B. Salom, T. Jover, M. D. Barbera & E. Alborch: Modulatory role of endothelial and nonendothelial nitric oxide in 5-hydroxytryptamine-induced contraction in cerebral arteries after subarachnoid hemorrhage. Neurosurgery 1996, 39, 998-1004.
24. Mizuno, K., M. Tani, S. Niimura, S. Hashimoto, A. Satoh, K. Shimamoto, T. Inagami & S. Fukuchi: Direct evidence for local generation and release of angiotensin II in human vascular tissue. Biochem. Biophys. Res. Commun. 1989, 165, 457-463.
25. 2+-sequestration in the smooth muscle of stroke-prone spontaneously hypertensive rats. Amer. J. Hypertens. 1999, 12, 590-595.
26. 1-receptor blockers in isolated vessels of different origin. Hypertension 1999, 33, 1406-1413.
27. Möller, S., L. Edvinsson & M. Adner: Transcriptional regulated plasticity of vascular contractile endothelin ET(B) receptors after organ culture. Eur. J. Pharmacol. 1997, 329, 69-77.
28. Nishimura, Y. & A. Suzuki: Enhanced contractile responses mediated by different 5-HT receptor subtypes in basilar arteries, superior mesenteric arteries and thoracic aortas from stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 1995, 22, S99-101.
29. Nozawa, Y., H. Miyake, A. Haruno, S. Yamada, S. Uchida, T. Ohkura, R. Kimura, H. Suzuki & T. Hoshino: Down-regulation of angiotensin II receptors in hypertrophied human myocardium. Clin. Exp. Pharmacol. Physiol. 1996, 23, 514-518.
30. 2 release in rat aortic endothelial cells is mediated by PKC. Prostaglandins. Leukot. Essent. Fatty Acids 1999, 61, 113-117.
31. Pantev, E., E. Stenman, A. Wackenfors, L. Edvinsson & M. Malmsjo: Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries. Eur. J. Heart Fail. 2002, 4, 699-705.
32. Ralevic, V., R. T. Mathie, B. Alexander & G. Burnstock: NG-nitro-L-arginine methyl ester attenuates vasodilator responses to acetylcholine but enhances those to sodium nitroprusside. J. Pharm. Pharmacol. 1991, 43, 871-874.
33. Regitz-Zagrosek, V., W. Auch-Schwelk, M. Neuss & E. Fleck: Regulation of the angiotensin receptor subtypes in cell cultures, animal models and human diseases. Eur. Heart J. 1994, 15, Suppl D, 92-97.
34. Saida, A., H. Ito, T. Shibuya & Y. Watanabe: Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res. Bull. 1997, 43, 69-80.
35. Sliva, D, D. English, D. Lyons & F. P. Lloyd: Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Biochem. Biophys. Res. Commun. 2002, 290, 552-557.
36. Stenman, E., M. Malmsjö, E. Uddman, G. Gido, T. Wieloch & L. Edvinsson: Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 2002, 33, 2311-2316.
37. 1 receptor-mediated contraction in rats. Stroke 2004, 35, 970-974.
38. Strohm, C., M. Barancik, M. von Bruehl, M. Strniskova, C. Ullmann, R. Zimmermann & W. Schaper: Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning. Cardiovasc. Res. 2002, 55, 602-618.
39. Touyz, R. M. & E. L. Schiffrin: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotension II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52, 639-672.
40. Trachsel, S. & H. U. Keller: Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes. J. Leukoc. Biol. 1995, 57, 587-591.
41. Tsutsumi, Y., H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, Y. Shibasaki, H. Kamihata, M. Inada & T. Iwasaka: Angiotensin II type 2 receptor is up-regulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ. Res. 1998, 83, 1035-1046.
42. Turla, M. B. & R. C. Webb: Vascular responsiveness to 5-hydroxytryptamine in experimental hypertension. In: The peripheral actions of 5-hydroxytryptamine. Ed.: J. R. Fozard. Oxford University Press, 1989, 327-353.
43. B receptor mRNA expression and contraction during organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2002, 452, 215-222.
44. B receptor up-regulation after organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2003, 482, 39-47.
45. Wackenfors, A., M. Emilson, R. Ingemansson, T. Hortobagyi, D. Szok, J. Tajti, L. Vecsei, L. Edvinsson & M. Malmsjö: Ischemic heart disease induce upregulation of endothelin receptor mRNA in human coronary arteries. Eur. J. Pharmacol. 2004, 484, 103-109.
46. Walther, T., L. Olah, C. Harms, B. Maul, M. Bader, H. Hortnagl, H. P. Schultheiss & G. Mies: Ischemic injury in experimental stroke depends on angiotensin II. FASEB. J. 2002, 16, 169-176.
47. 2A receptor. Ann. N. Y. Acad. Sci. 1998, 861, 162-168.
48. Watts, S. W.: Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension 2002, 39, 825-829.
49. Xu, K. & T. J. Murphy: Reconstitution of angiotensin receptor mRNA down-regulation in vascular smooth muscle. Post-transcriptional control by protein kinase a A but not mitogenic signaling directed by the 5′-untranslated region. J. Biol. Chem. 2000, 275, 7604-7611.
50. Yildiz, O., J. R. Smith & R. E. Purdy: Serotonin and vasoconstrictor synergism. Life Sci. 1998, 62, 1723-1732.
51. 1-receptor activation of human omental arteries. JRAAS 2001, 2, 42-47.
52. Zemin, C., D. Rachael, W. Leonard, C. David & E. C. Mark: Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999, 34, 408-414.
53. Zhu, Y. Z., G. N. Chimon, Y. C. Zhu, Q. Lu, B. Li, H. Z. Hu, E. H. Yap, H. S. Lee & P. T. Wong: Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats. Neuroreport 2000, 11, 1191-1194.